Difesa Capital Management’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-10,000	Closed	-$22.9K	–	11
2023 Q2	$22.9K	Buy	+10,000	New	+$22.9K	0.06%	32